| Serial Number | 79314660 |
| Word Mark | CELLIXIR |
| Filing Date | Friday, March 12, 2021 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 5, 2024 |
| Goods and Services | Pharmaceutical and veterinary preparations, namely, cells, tissues, and grafts engineering reagent for medical or veterinary purposes; diagnostic preparations for medical and veterinary use; living cells and cultures of microorganisms as well as protein arrays, synthetic peptides for the treatment of blood, genetic, and immune disorders and cancer and nucleic acid sequences and complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for medical and veterinary use; living cells and cultures of microorganisms as well as proteins arrays, synthetic peptides and nucleic acids sequences and complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for medical and clinical use for the treatment of genetic defects in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use, in particular for the diagnosis and analysis of genetic defects, viral and infectious diseases, cardiovascular diseases and cancer; living cells, cultures of microorganisms, and proteins arrays, synthetic peptides and nucleic acids sequences and complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for medical and veterinary use, in particular for medical and clinical use for the treatment of genetic defects in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer |
| Goods and Services | Chemicals and biochemical products for industrial and scientific use and not for medical or veterinary use, for transferring biological molecules into living cells and for integrating foreign nucleic acids into the genome of living cells; chemical and biochemical soluble substances and solutions for industrial use and not for medical or veterinary purposes, for the transfer of chemical or biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; biological preparations for laboratory use, other than for medical and veterinary use; diagnostic preparations, other than for medical and veterinary use; peptide substrates, protein arrays and nucleic acids or complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes for clinical or medical laboratory use, for identifying genetic expression and protein location and integration of foreign nucleic acids into the genome of living cells; chemical and biochemical preparations for industrial and scientific use; chemical and biochemical soluble substances and solutions for industrial use and not for medical or veterinary purposes, for cellular and gene engineering and analysis in laboratories; Chemicals, namely, standard solutions and buffers used in analytical chemistry for transferring chemical and biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins or nucleic acids; aqueous chemical and biochemical solutions containing nutrients for cultivating living cells for use in electroporation; biological cell and tissue cultures for laboratory use other than for medical and veterinary use; diagnostic reagents other than for medical and veterinary use; peptide substrates, protein array and nucleic acids or complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for clinical or medical laboratory use, in particular for detecting and monitoring, and for integrating foreign nucleic acids into the genome of living cells and transient production of proteins; transfection reagents in the nature of chemical and biochemical reagents, used for transient production of proteins, other than for medical and veterinary use |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 6, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CELLECTIS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | CELLECTIS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Event Date | Event Description |
| Tuesday, July 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, July 10, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 12, 2021 | ASSIGNED TO EXAMINER |
| Thursday, July 1, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, October 27, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, October 28, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, April 25, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 25, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, October 29, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, October 29, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, November 23, 2021 | REFUSAL PROCESSED BY IB |
| Monday, April 25, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 25, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 25, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 26, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 27, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, January 26, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, August 10, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Sunday, June 12, 2022 | SUSPENSION LETTER WRITTEN |
| Sunday, June 12, 2022 | LETTER OF SUSPENSION E-MAILED |
| Sunday, June 12, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, December 7, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, December 7, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, November 18, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, February 14, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, April 4, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, April 4, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, April 4, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, September 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 9, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, September 30, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 30, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 30, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 30, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, September 30, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 16, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 5, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 5, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |